Chimerix is a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases.
|Jun 24, 2022|
|Jun 23, 2022|
|Jun 01, 2022|
|May 17, 2022|
Mar 24, 2022
The Chimerix ticker is CMRX and it is traded on the Nasdaq Global Market.
2505 Meridian Parkway, Suite 100, Durham, NC 27713
You can view our Board of Directors by visiting the Board of Directors section of our Investor Relations website.
You can view our management team by visiting the Management section of our Investor Relations website.
Chimerix does not expect to declare or pay any cash or other dividends on our common stock.
The transfer agent and registrar for our common stock is: Computershare Trust Company, N.A. The transfer agent and registrar’s address is: P.O. Box 43078 Providence, Rhode Island 02940